GET READY FOR A DRUG DELIVERY REVOLUTION

New devices are poised to defeat the age-old compliance problem for glaucoma patients.

By Savak “Sev” Teymoorian, MD, MBA

VISUAL FIELD TESTING IN THE CLINIC

A look at visual field progression and various testing protocols

By Brian C. Stagg, MD, MS, Catherine Johnson, MD, MPH

AI PROMISES TO TRANSFORM GLAUCOMA CARE

A look at the novel ways artificial intelligence is being used to conduct glaucoma screenings and identify progression

By Alessandro A. Jammal, MD, PhD

CREATE A SUCCESSFUL GLAUCOMA SCREENING PROGRAM

What to consider when providing glaucoma education and screenings in your community

By Daniel Laroche, MD, Kara Rickford Grimes, MSc

DIFFERENTIATING MYOPIA AND GLAUCOMA

Navigate the challenges in identifying glaucoma in myopic eyes and help your patients preserve their visual function.

By Kateki Vinod, MD

GLAUCOMA TREATMENTS COMING DOWN THE PIPELINE

Innovation may lead to more effective therapies

By Steve Lenier

LESSONS LEARNED

Embrace new technology

By Reay H. Brown, MD

FINANCIAL FACTOR

Wake up to medical practice reality

By Scott LaBorwit, MD

BENZALKONIUM CHLORIDE AND ITS EFFECT ON THE OCULAR SURFACE

BAK and preservative-free alternatives in the disruption of ocular surface homeostasis

By Beeran Meghpara, MD, Manjool Shah, MD

Guest Editorial: Innovations in Glaucoma Treatment and Diagnosis

This issue focuses on both exciting and challenging aspects of care for glaucoma patients.

By SWARUP S. SWAMINATHAN, MD

CODING & REIMBURSEMENT

Office-based cataract surgery and coding

By BRITTNEY IRWIN, COT, CPC-A, CEP

QUICK HITS

What's new in glaucoma, plus the latest news in ophthalmology

RX PERSPECTIVE

New drug 'mite' be the cure for Demodex blepharitis

By Joseph Jalkiewicz

INDUSTRY INSIDER

Topcon Healthcare’s Mary Durbin

ASCRS 2024 PREPARES FOR ‘HISTORICAL’ EXPERIENCE

Highlights of the upcoming annual meeting in Boston include a celebration of the society’s 50th anniversary.